Nifty
Sensex
:
:
17629.50
59141.16
110.05 (0.63%)
417.96 (0.71%)

Pharmaceuticals & Drugs - API

Rating :
56/99

BSE: 500288 | NSE: MOREPENLAB

57.85
16-Sep-2021
  • Open
  • High
  • Low
  • Previous Close
  •  59.55
  •  59.70
  •  57.60
  •  59.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1460427
  •  849.32
  •  75.00
  •  22.35

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,665.22
  • 24.63
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,759.46
  • N/A
  • 5.85

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 34.54%
  • 4.06%
  • 43.90%
  • FII
  • DII
  • Others
  • 0.68%
  • 1.85%
  • 14.97%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.09
  • 11.95
  • 12.04

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 28.07
  • 2.17
  • 1.14

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 21.28
  • 4.31

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.05
  • 31.25
  • 25.31

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.20
  • 4.56
  • 3.87

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.68
  • 15.15
  • 13.11

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Net Sales
386.73
257.64
50.10%
286.60
206.60
38.72%
307.42
230.06
33.63%
336.39
213.43
57.61%
Expenses
342.88
231.07
48.39%
256.20
187.78
36.44%
277.63
214.75
29.28%
304.64
198.37
53.57%
EBITDA
43.85
26.57
65.04%
30.40
18.83
61.44%
29.79
15.30
94.71%
31.75
15.06
110.82%
EBIDTM
11.34%
10.31%
10.61%
9.11%
9.69%
6.65%
9.44%
7.05%
Other Income
1.58
1.33
18.80%
4.16
1.79
132.40%
2.84
4.60
-38.26%
3.73
2.81
32.74%
Interest
0.21
0.29
-27.59%
-0.05
0.62
-
1.27
0.54
135.19%
0.29
0.39
-25.64%
Depreciation
6.69
8.06
-17.00%
6.98
8.63
-19.12%
7.56
8.54
-11.48%
7.68
8.24
-6.80%
PBT
38.53
19.55
97.08%
27.64
11.36
143.31%
23.80
10.82
119.96%
27.52
9.24
197.84%
Tax
8.06
0.19
4,142.11%
0.87
0.34
155.88%
0.01
0.01
0.00%
0.35
5.15
-93.20%
PAT
30.47
19.37
57.31%
26.76
11.02
142.83%
23.79
10.82
119.87%
27.17
4.09
564.30%
PATM
7.88%
7.52%
9.34%
5.33%
7.74%
4.70%
8.08%
1.92%
EPS
0.68
0.43
58.14%
0.59
0.25
136.00%
0.53
0.24
120.83%
0.60
0.09
566.67%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
1,317.14
853.07
768.54
606.51
595.47
485.08
400.64
366.85
325.92
289.34
228.30
Net Sales Growth
45.10%
11.00%
26.72%
1.85%
22.76%
21.08%
9.21%
12.56%
12.64%
26.74%
 
Cost Of Goods Sold
876.44
524.19
479.12
361.28
358.35
293.33
238.62
209.04
193.53
178.07
142.68
Gross Profit
440.70
328.87
289.42
245.23
237.12
191.76
162.02
157.81
132.39
111.27
85.62
GP Margin
33.46%
38.55%
37.66%
40.43%
39.82%
39.53%
40.44%
43.02%
40.62%
38.46%
37.50%
Total Expenditure
1,181.35
784.55
701.02
541.78
534.09
423.52
352.41
317.95
294.97
270.11
222.53
Power & Fuel Cost
-
12.56
13.18
11.08
9.84
7.64
7.41
8.42
8.96
9.82
7.69
% Of Sales
-
1.47%
1.71%
1.83%
1.65%
1.57%
1.85%
2.30%
2.75%
3.39%
3.37%
Employee Cost
-
109.91
95.36
76.53
69.69
58.29
48.79
45.08
39.17
36.05
30.52
% Of Sales
-
12.88%
12.41%
12.62%
11.70%
12.02%
12.18%
12.29%
12.02%
12.46%
13.37%
Manufacturing Exp.
-
48.92
31.28
16.21
22.36
13.33
12.68
12.23
11.33
10.20
11.40
% Of Sales
-
5.73%
4.07%
2.67%
3.76%
2.75%
3.16%
3.33%
3.48%
3.53%
4.99%
General & Admin Exp.
-
36.47
36.14
28.52
18.11
18.14
15.89
16.62
13.86
14.37
12.72
% Of Sales
-
4.28%
4.70%
4.70%
3.04%
3.74%
3.97%
4.53%
4.25%
4.97%
5.57%
Selling & Distn. Exp.
-
40.11
32.73
30.04
25.79
23.45
21.40
19.55
20.40
15.85
11.26
% Of Sales
-
4.70%
4.26%
4.95%
4.33%
4.83%
5.34%
5.33%
6.26%
5.48%
4.93%
Miscellaneous Exp.
-
12.39
13.20
18.11
29.95
9.35
7.61
7.01
7.72
5.75
11.26
% Of Sales
-
1.45%
1.72%
2.99%
5.03%
1.93%
1.90%
1.91%
2.37%
1.99%
2.74%
EBITDA
135.79
68.52
67.52
64.73
61.38
61.56
48.23
48.90
30.95
19.23
5.77
EBITDA Margin
10.31%
8.03%
8.79%
10.67%
10.31%
12.69%
12.04%
13.33%
9.50%
6.65%
2.53%
Other Income
12.31
9.48
3.67
3.72
3.72
1.20
1.37
1.22
2.87
1.18
1.04
Interest
1.72
1.98
2.11
4.36
7.56
10.50
8.66
9.92
11.63
7.96
6.27
Depreciation
28.91
36.91
39.90
34.32
33.90
35.20
38.67
45.84
45.80
48.06
48.16
PBT
117.49
39.11
29.18
29.77
23.63
17.06
2.28
-5.64
-23.61
-35.61
-47.62
Tax
9.29
5.53
0.34
0.00
0.00
-0.13
0.14
0.01
-0.01
0.06
-0.69
Tax Rate
7.91%
14.14%
1.17%
0.00%
0.00%
-1.03%
6.14%
-0.36%
0.05%
-0.25%
1.45%
PAT
108.19
33.58
28.85
29.59
23.63
12.80
2.14
-2.77
-20.52
-23.65
-46.93
PAT before Minority Interest
108.18
33.58
28.84
29.77
23.63
12.80
2.14
-2.75
-20.52
-23.63
-46.93
Minority Interest
-0.01
0.00
0.01
-0.18
0.00
0.00
0.00
-0.02
0.00
-0.02
0.00
PAT Margin
8.21%
3.94%
3.75%
4.88%
3.97%
2.64%
0.53%
-0.76%
-6.30%
-8.17%
-20.56%
PAT Growth
138.83%
16.40%
-2.50%
25.22%
84.61%
498.13%
-
-
-
-
 
EPS
2.41
0.75
0.64
0.66
0.53
0.28
0.05
-0.06
-0.46
-0.53
-1.04

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
284.06
253.09
225.94
196.26
300.28
287.48
297.11
299.88
320.40
344.05
Share Capital
89.96
89.96
89.96
89.96
209.61
209.61
209.61
209.61
209.61
209.61
Total Reserves
194.10
163.13
135.98
106.30
90.67
77.87
87.50
90.27
110.79
134.44
Non-Current Liabilities
28.42
23.38
20.20
17.80
57.47
74.00
84.65
103.91
122.05
135.01
Secured Loans
0.92
1.83
2.95
1.38
43.41
62.27
74.78
94.65
98.85
114.37
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
15.04
14.32
Long Term Provisions
23.82
19.01
14.42
13.59
11.34
9.22
7.82
7.17
5.73
3.90
Current Liabilities
351.44
339.17
340.12
324.86
166.56
127.92
108.14
102.73
104.95
102.78
Trade Payables
172.30
168.15
174.88
124.88
115.33
84.96
68.60
56.81
64.98
59.79
Other Current Liabilities
165.06
160.64
163.90
198.65
47.04
39.87
37.58
45.22
38.96
41.11
Short Term Borrowings
11.36
8.99
0.00
0.00
0.00
2.23
1.19
0.00
0.00
0.00
Short Term Provisions
2.72
1.39
1.33
1.33
4.19
0.86
0.77
0.70
1.01
1.88
Total Liabilities
663.46
615.18
585.81
538.29
523.68
489.00
489.50
506.09
546.98
581.40
Net Block
216.37
236.21
264.29
271.80
296.72
322.48
368.08
409.46
451.86
496.02
Gross Block
752.55
887.76
997.60
1,026.96
1,018.43
1,009.35
1,004.61
1,000.44
997.38
997.96
Accumulated Depreciation
536.18
651.55
733.31
755.15
721.72
686.87
636.53
590.98
545.52
501.94
Non Current Assets
291.29
315.71
342.37
346.34
366.53
374.42
393.18
415.00
457.37
501.38
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investment
1.08
0.00
0.00
0.00
0.00
0.00
0.00
3.87
3.87
3.97
Long Term Loans & Adv.
73.55
79.22
77.81
73.69
69.82
51.94
25.10
1.67
1.64
1.39
Other Non Current Assets
0.28
0.28
0.27
0.85
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
372.18
299.47
243.44
191.95
157.15
114.58
96.32
91.09
89.61
80.02
Current Investments
0.00
0.02
0.22
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
138.48
94.20
76.89
64.66
42.14
37.11
33.30
37.05
38.66
34.70
Sundry Debtors
137.68
133.75
121.85
92.95
87.94
56.14
42.67
39.11
35.15
29.64
Cash & Bank
38.88
32.21
5.95
7.59
4.36
8.85
9.11
5.53
4.51
2.58
Other Current Assets
57.14
7.86
5.62
4.71
22.71
12.48
11.24
9.40
11.29
13.10
Short Term Loans & Adv.
51.16
31.43
32.92
22.03
16.77
9.34
8.23
6.23
9.60
10.30
Net Current Assets
20.73
-39.70
-96.68
-132.92
-9.41
-13.34
-11.82
-11.64
-15.34
-22.76
Total Assets
663.47
615.18
585.81
538.29
523.68
489.00
489.50
506.09
546.98
581.40

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
11.02
17.37
63.41
40.73
50.07
50.70
33.52
33.64
27.11
11.13
PBT
39.11
29.18
29.77
23.04
17.06
2.28
-5.64
-23.60
-35.61
-47.62
Adjustment
36.63
40.32
38.64
41.40
45.69
47.32
55.76
56.80
55.99
54.44
Changes in Working Capital
-58.84
-51.78
-5.00
-23.72
-8.41
1.23
-19.50
-2.64
-5.25
3.63
Cash after chg. in Working capital
16.89
17.71
63.41
40.73
54.34
50.83
30.62
30.56
15.13
10.45
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-5.88
-0.34
0.00
0.00
0.13
-0.13
0.01
0.01
-0.06
0.68
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
-4.40
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-12.46
-13.05
-26.93
-13.60
-27.30
-31.65
-0.80
-2.83
-3.35
-4.05
Net Fixed Assets
135.60
113.16
31.96
-8.08
-7.02
-4.73
-4.09
-2.87
0.60
-2.41
Net Investments
-1.07
0.20
-0.22
0.00
0.25
0.00
3.87
0.00
0.10
0.00
Others
-146.99
-126.41
-58.67
-5.52
-20.53
-26.92
-0.58
0.04
-4.05
-1.64
Cash from Financing Activity
5.49
-0.44
-37.77
-23.72
-27.26
-19.31
-29.14
-29.79
-21.83
-5.60
Net Cash Inflow / Outflow
4.04
3.88
-1.29
3.40
-4.49
-0.26
3.58
1.02
1.93
1.48
Opening Cash & Equivalents
9.60
5.72
7.00
3.60
8.85
9.11
5.53
4.51
2.58
1.10
Closing Cash & Equivalent
13.64
9.60
5.72
7.00
4.36
8.85
9.11
5.53
4.51
2.58

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
6.32
5.63
5.02
4.36
4.02
3.73
3.95
4.01
4.46
4.99
ROA
5.25%
4.80%
5.30%
4.45%
2.53%
0.44%
-0.55%
-3.90%
-4.19%
-7.84%
ROE
12.50%
12.04%
14.10%
12.54%
7.35%
1.24%
-1.54%
-10.77%
-11.12%
-18.99%
ROCE
10.25%
10.01%
14.05%
10.18%
6.29%
2.90%
1.80%
-2.09%
-3.40%
-8.22%
Fixed Asset Turnover
1.04
0.82
0.60
0.58
0.49
0.41
0.37
0.33
0.29
0.23
Receivable days
58.07
60.70
64.63
55.44
53.22
44.17
40.16
40.83
40.35
42.17
Inventory Days
49.78
40.63
42.59
32.73
29.27
31.48
34.55
41.63
45.68
52.36
Payable days
79.06
88.85
103.38
82.97
83.88
76.01
67.69
69.30
75.59
101.91
Cash Conversion Cycle
28.78
12.48
3.85
5.20
-1.39
-0.36
7.02
13.16
10.44
-7.39
Total Debt/Equity
0.47
0.52
0.06
0.25
0.22
0.28
0.30
0.37
0.38
0.39
Interest Cover
20.71
14.83
7.83
4.13
2.21
1.26
0.72
-0.77
-1.96
-6.59

News Update:


  • Morepen Laboratories incorporates wholly owned subsidiary company
    7th Sep 2021, 15:58 PM

    The company has incorporated a wholly owned subsidiary namely ‘Morepen Devices’on September 06, 2021

    Read More
  • Morepen Laboratories, RDIF start production of test batch of Sputnik V in India
    6th Jul 2021, 14:05 PM

    The first batch will be shipped to the Gamaleya Center for the quality control

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.